In 2009, with the low-hanging fruit in protein-targeting drug discovery already picked, Nymirum was founded to open up an entire new forest: targeting RNA with small molecules.

Nymirum, Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://nymirum.com
Disease Focus
STOCK CODENon Listed
Address4324 S. Alston Ave. Ste 110, NC, 27713DurhamUnited States
4324 S. Alston Ave. Ste 110, NC, 27713
Durham
United States
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/nymirum” connections=”true” suffix=””]